Global Fungal Keratitis Treatment Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	170 Pages	TechNavio	September, 2024	INF19463260

Best Price Guarantee
Price	from $2,500
Length	170 Pages
Publisher	TechNavio
Published Date	September, 2024
SKU	INF19463260

Fungal Keratitis Treatment Market 2024-2028

The fungal keratitis treatment market is forecasted to grow by USD 188 mn during 2023-2028, accelerating at a CAGR of 4.2% during the forecast period. The report on the fungal keratitis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing awareness about eye diseases, presence of online sites selling fungal keratitis treatment drugs, and increasing innovation of ocular novel drug delivery systems.

Technavio's fungal keratitis treatment market is segmented as below:

By Route Of Administration

Oral
Injection
Topical

By Distribution Channel

Hospitals
Drug stores
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in funding for research on ophthalmic diseases as one of the prime reasons driving the fungal keratitis treatment market growth during the next few years. Also, emerging new targets for treatment of fungal keratitis and rising demand for non-invasive fungal keratitis tests will lead to sizable demand in the market.

The report on the fungal keratitis treatment market covers the following areas:

Fungal Keratitis Treatment Market sizing
Fungal Keratitis Treatment Market forecast
Fungal Keratitis Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fungal keratitis treatment market vendors that include A.S. Lifesciences, Alvogen Inc, Aravind Eye Care System, Astellas Pharma Inc., Bayer AG, Cipla Inc., Gilead Sciences Inc., Glenmark Pharmaceuticals Ltd., Goldfield Healthcare, Grevis Pharmaceuticals Pvt. Ltd., ISKON REMEDIES and GMT, Merck and Co. Inc., Novartis AG, Novo Holdings AS, Omicron Pharma, Pfizer Inc., Santen Pharmaceutical Co. Ltd., Taj Pharmaceutical Ltd., Viatris Inc., and Wellona Pharma. Also, the fungal keratitis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Fungal Keratitis Treatment Market 2018 - 2022; Historic Market Size - Data Table on Global Fungal Keratitis Treatment Market 2018 - 2022 ($ million); 4.2 Route of Administration segment analysis 2018 - 2022; Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million); 4.3 Distribution Channel segment analysis 2018 - 2022; Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Route of Administration: 6.1 Market segments; Chart on Route of Administration - Market share 2023-2028 (%); Data Table on Route of Administration - Market share 2023-2028 (%); 6.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 6.3 Oral - Market size and forecast 2023-2028; Chart on Oral - Market size and forecast 2023-2028 ($ million); Data Table on Oral - Market size and forecast 2023-2028 ($ million); Chart on Oral - Year-over-year growth 2023-2028 (%); Data Table on Oral - Year-over-year growth 2023-2028 (%); 6.4 Injection - Market size and forecast 2023-2028; Chart on Injection - Market size and forecast 2023-2028 ($ million); Data Table on Injection - Market size and forecast 2023-2028 ($ million); Chart on Injection - Year-over-year growth 2023-2028 (%); Data Table on Injection - Year-over-year growth 2023-2028 (%); 6.5 Topical - Market size and forecast 2023-2028; Chart on Topical - Market size and forecast 2023-2028 ($ million); Data Table on Topical - Market size and forecast 2023-2028 ($ million); Chart on Topical - Year-over-year growth 2023-2028 (%); Data Table on Topical - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
7 Market Segmentation by Distribution Channel: 7.1 Market segments; Chart on Distribution Channel - Market share 2023-2028 (%); Data Table on Distribution Channel - Market share 2023-2028 (%); 7.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 7.3 Hospitals - Market size and forecast 2023-2028; Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Chart on Hospitals - Year-over-year growth 2023-2028 (%); Data Table on Hospitals - Year-over-year growth 2023-2028 (%); 7.4 Drug stores - Market size and forecast 2023-2028; Chart on Drug stores - Market size and forecast 2023-2028 ($ million); Data Table on Drug stores - Market size and forecast 2023-2028 ($ million); Chart on Drug stores - Year-over-year growth 2023-2028 (%); Data Table on Drug stores - Year-over-year growth 2023-2028 (%); 7.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.11 India - Market size and forecast 2023-2028; Chart on India - Market size and forecast 2023-2028 ($ million); Data Table on India - Market size and forecast 2023-2028 ($ million); Chart on India - Year-over-year growth 2023-2028 (%); Data Table on India - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Alvogen; Alvogen - Overview; Alvogen - Product / Service; Alvogen - Key offerings; 12.4 Aravind Eye Care System; Aravind Eye Care System - Overview; Aravind Eye Care System - Product / Service; Aravind Eye Care System - Key offerings; 12.5 Astellas Pharma Inc.; Astellas Pharma Inc. - Overview; Astellas Pharma Inc. - Product / Service; Astellas Pharma Inc. - Key offerings; 12.6 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.7 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; 12.8 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; 12.9 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; 12.10 ISKON REMEDIES and GMT; ISKON REMEDIES and GMT - Overview; ISKON REMEDIES and GMT - Product / Service; ISKON REMEDIES and GMT - Key offerings; 12.11 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; 12.12 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.13 Novo Holdings AS; Novo Holdings AS - Overview; Novo Holdings AS - Product / Service; Novo Holdings AS - Key offerings; 12.14 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.15 Santen Pharmaceutical Co. Ltd.; Santen Pharmaceutical Co. Ltd. - Overview; Santen Pharmaceutical Co. Ltd. - Product / Service; Santen Pharmaceutical Co. Ltd. - Key offerings; 12.16 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus; 12.17 Wellona Pharma; Wellona Pharma - Overview; Wellona Pharma - Product / Service; Wellona Pharma - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Fungal Keratitis Treatment Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Route of Administration - Market share 2023-2028 (%); Exhibits33: Data Table on Route of Administration - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Route of Administration; Exhibits35: Data Table on Comparison by Route of Administration; Exhibits36: Chart on Oral - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Oral - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Oral - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Oral - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Injection - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Injection - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Injection - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Injection - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Topical - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Topical - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Topical - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Topical - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by Route of Administration ($ million); Exhibits49: Data Table on Market opportunity by Route of Administration ($ million); Exhibits50: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits51: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Distribution Channel; Exhibits53: Data Table on Comparison by Distribution Channel; Exhibits54: Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Drug stores - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Drug stores - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Drug stores - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Drug stores - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Distribution Channel ($ million); Exhibits67: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on India - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on India - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ million); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: Alvogen - Overview; Exhibits118: Alvogen - Product / Service; Exhibits119: Alvogen - Key offerings; Exhibits120: Aravind Eye Care System - Overview; Exhibits121: Aravind Eye Care System - Product / Service; Exhibits122: Aravind Eye Care System - Key offerings; Exhibits123: Astellas Pharma Inc. - Overview; Exhibits124: Astellas Pharma Inc. - Product / Service; Exhibits125: Astellas Pharma Inc. - Key offerings; Exhibits126: Bayer AG - Overview; Exhibits127: Bayer AG - Business segments; Exhibits128: Bayer AG - Key news; Exhibits129: Bayer AG - Key offerings; Exhibits130: Bayer AG - Segment focus; Exhibits131: Cipla Inc. - Overview; Exhibits132: Cipla Inc. - Business segments; Exhibits133: Cipla Inc. - Key news; Exhibits134: Cipla Inc. - Key offerings; Exhibits135: Cipla Inc. - Segment focus; Exhibits136: Gilead Sciences Inc. - Overview; Exhibits137: Gilead Sciences Inc. - Product / Service; Exhibits138: Gilead Sciences Inc. - Key news; Exhibits139: Gilead Sciences Inc. - Key offerings; Exhibits140: Glenmark Pharmaceuticals Ltd. - Overview; Exhibits141: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibits142: Glenmark Pharmaceuticals Ltd. - Key offerings; Exhibits143: ISKON REMEDIES and GMT - Overview; Exhibits144: ISKON REMEDIES and GMT - Product / Service; Exhibits145: ISKON REMEDIES and GMT - Key offerings; Exhibits146: Merck and Co. Inc. - Overview; Exhibits147: Merck and Co. Inc. - Business segments; Exhibits148: Merck and Co. Inc. - Key news; Exhibits149: Merck and Co. Inc. - Key offerings; Exhibits150: Merck and Co. Inc. - Segment focus; Exhibits151: Novartis AG - Overview; Exhibits152: Novartis AG - Business segments; Exhibits153: Novartis AG - Key news; Exhibits154: Novartis AG - Key offerings; Exhibits155: Novartis AG - Segment focus; Exhibits156: Novo Holdings AS - Overview; Exhibits157: Novo Holdings AS - Product / Service; Exhibits158: Novo Holdings AS - Key offerings; Exhibits159: Pfizer Inc. - Overview; Exhibits160: Pfizer Inc. - Product / Service; Exhibits161: Pfizer Inc. - Key news; Exhibits162: Pfizer Inc. - Key offerings; Exhibits163: Santen Pharmaceutical Co. Ltd. - Overview; Exhibits164: Santen Pharmaceutical Co. Ltd. - Product / Service; Exhibits165: Santen Pharmaceutical Co. Ltd. - Key offerings; Exhibits166: Viatris Inc. - Overview; Exhibits167: Viatris Inc. - Business segments; Exhibits168: Viatris Inc. - Key news; Exhibits169: Viatris Inc. - Key offerings; Exhibits170: Viatris Inc. - Segment focus; Exhibits171: Wellona Pharma - Overview; Exhibits172: Wellona Pharma - Product / Service; Exhibits173: Wellona Pharma - Key offerings; Exhibits174: Inclusions checklist; Exhibits175: Exclusions checklist; Exhibits176: Currency conversion rates for US$; Exhibits177: Research methodology; Exhibits178: Information sources; Exhibits179: Data validation; Exhibits180: Validation techniques employed for market sizing; Exhibits181: Data synthesis; Exhibits182: 360 degree market analysis; Exhibits183: List of abbreviations